Top-End of Guidance and Strong Profitability
Finished FY2025 at the top end of full-year guidance; GAAP EPS of $3.20 and adjusted EPS of $4.73 for the year; generated $425M in adjusted EBITDA with an adjusted EBITDA margin of 8.5% for 2025.
Robust Cash Generation and Improved Conversion
Generated $303M net cash provided by operating activities and $234M in free cash flow for 2025, representing 16% year-over-year free cash flow growth; free cash flow conversion improved from 41% in 2024 to 55% in 2025 (moving toward a 60–65% target).
Disciplined Expense Management
Operating expenses (ex-insurance and interest) declined 16% in Q4 and 7% year over year for the full year; overall expenses down 7% YoY exiting 2025, with further improvement expected in 2026.
Improved Insurance Pricing and Risk Position
Completed comprehensive health fee renewals and repricing actions, improving pricing quality and actuarial discipline; insurance services revenue per average co-employed WSE grew ~9% in 2025 as health fees were passed through.
ASO Growth and Product Mix Expansion
ASO users exceeded 39,000 with an average revenue per user of ~ $50 (roughly three times legacy SaaS-only levels); conversion rates from legacy HRIS to ASO exceeded expectations and contributed materially to ASO growth.
Go-to-Market Momentum and Sales Investment Payoff
Early 2026 sales momentum: strong January sales, brokerage channel progress (four national partners entering 2026), double-digit growth in tenured reps (>4 years), and planned ~20% expansion in selling capacity later in the year via Ascend and other investments.
Customer Experience and Technology Advancements
Achieved an all-time high Net Promoter Score in 2025 and announced TriNet Assistant (AI-powered HR tool) plus strategic integrations (international employment, contractor management, IT provisioning, leave of absence) to improve retention and value.
Shareholder Returns and Capital Positioning
Returned $235M to shareholders in 2025 via dividends ($1.075 per share for the year) and repurchases (~2.8M shares for $182M); Board increased share repurchase authorization to $400M; paid down debt and exited 2025 with debt/adjusted EBITDA of 2.1x.